Dihydroimidazo[4,5-e]indole and 7H-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands

Details for Australian Patent Application No. 2002310904 (hide)

Owner Merck Patent GmbH

Inventors Leibrock, Joachim; Schiemann, Kai; Bottcher, Henning

Agent Davies Collison Cave

Pub. Number AU-B-2002310904

PCT Number PCT/EP02/03582

PCT Pub. Number WO2002/088143

Priority 101 21 215.1 30.04.01 DE

Filing date 30 March 2002

Wipo publication date 11 November 2002

Acceptance publication date 10 January 2008

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 101 21 215.1 30.04.01 DE

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002310904

10 January 2008 Application Accepted

  Published as AU-B-2002310904

8 May 2008 Standard Patent Sealed

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002310905-Indolinones, substituted in position 6, and their use as kinase inhibitors

2002310903-Vaccine composition